Novartis Investigative Site

Fredericksburg, Virginia 22408

0 studies enrolling now · 4 studies all time

What they study most

Chronic Obstructive Pulmonary Disease, Chronic Obstructive Pulmonary Disease (COPD), Heart Failure With Reduced Ejection Fraction, Non-Hodgkin's Lymphoma

Studies at this site

• Single Agent Ofatumumab Vs. Single Agent Rituximab in Indolent B-Cell Non Hodgkin Lymphoma Relapsed After Rituximab-Containing Therapy — Stopped early
• This Study Will Evaluate the Efficacy and Safety of LCZ696 Compared to Enalapril on Morbidity and Mortality of Patients With Chronic Heart Failure — Stopped early
• Long Term Safety Study of NVA237 vs QAB149 in COPD Patients — Completed
• Efficacy and Safety of Different Doses of Indacaterol in Chronic Obstructive Pulmonary Disease (COPD) — Completed